Lang C H, Dobrescu C
Department of Physiology, Louisiana State University Medical Center, New Orleans 70112.
Circ Shock. 1992 Oct;38(2):91-102.
An inhibitory effect of fatty acid oxidation on glucose uptake and oxidation has been demonstrated in heart and skeletal muscle under certain experimental conditions. This reciprocal relationship has been termed the glucose-fatty acid cycle. The purpose of the present study was to determine under in vivo conditions whether this interaction was operational in various nonmuscle tissues, and whether infection altered the activity of this cycle. Oral administration of alpha-methylpalmoxirate (MPA; 75 mg/kg), a known inhibitor of long-chain fatty acid oxidation, suppressed hepatic glucose production by 54% and increased whole body glucose disappearance by 15% in nonseptic rats. In contrast, MPA produced a larger reduction of glucose output in septic rats, but did not enhance glucose disposal. In vivo glucose uptake (Rg) by individual tissues was determined using the tracer 2-deoxyglucose technique. In nonseptic animals, MPA increased Rg in "working" muscles (heart and diaphragm; 12-fold and two-fold respectively), but not in "resting" skeletal muscles. MPA increased the Rg of heart and diaphragm to the same level in septic animals. Inhibition of fatty acid oxidation in nonseptic rats also enhanced Rg in liver (174%), spleen (158%), lung (153%), ileum (52%), skin (28%), kidney (115%), and epididymal fat (135%). In septic rats, MPA only increased Rg in the ileum (23%) and kidney (50%). This increased glucose uptake was independent of increases in plasma glucose and insulin concentrations. The infusion of heparin and intralipid, which increased circulating levels of fatty acids, failed to produce consistent changes in either the whole body glucose turnover or glucose uptake by individual tissues. We conclude that under basal in vivo conditions the inhibition of fatty acid oxidation suppresses glucose production and increases peripheral glucose disposal in nonseptic animals. These data support the presence of the glucose-fatty acid cycle in nonmuscle tissues and emphasizes its importance in whole body glucose homeostasis in situations where fatty acid oxidation is impaired. Infection increases glucose uptake by nonmuscle tissues which, for the most part, cannot be further enhanced by the inhibition of lipid oxidation.
在某些实验条件下,脂肪酸氧化对心脏和骨骼肌的葡萄糖摄取及氧化具有抑制作用。这种相互关系被称为葡萄糖 - 脂肪酸循环。本研究的目的是在体内条件下确定这种相互作用在各种非肌肉组织中是否起作用,以及感染是否会改变这个循环的活性。口服α - 甲基棕榈酰辅酶A酯(MPA;75毫克/千克),一种已知的长链脂肪酸氧化抑制剂,可使非脓毒症大鼠的肝脏葡萄糖生成减少54%,并使全身葡萄糖消失增加15%。相比之下,MPA使脓毒症大鼠的葡萄糖输出减少幅度更大,但并未增强葡萄糖的处置。使用示踪剂2 - 脱氧葡萄糖技术测定各个组织的体内葡萄糖摄取(Rg)。在非脓毒症动物中,MPA增加了“工作”肌肉(心脏和膈肌;分别增加12倍和2倍)的Rg,但未增加“静止”骨骼肌的Rg。在脓毒症动物中,MPA使心脏和膈肌的Rg增加到相同水平。抑制非脓毒症大鼠的脂肪酸氧化也增强了肝脏(174%)、脾脏(158%)、肺(153%)、回肠(52%)、皮肤(28%)、肾脏(115%)和附睾脂肪(135%)的Rg。在脓毒症大鼠中,MPA仅增加了回肠(23%)和肾脏(50%)的Rg。这种增加的葡萄糖摄取与血浆葡萄糖和胰岛素浓度的增加无关。输注肝素和脂质乳剂,这会增加循环中的脂肪酸水平,但未能使全身葡萄糖周转率或各个组织的葡萄糖摄取产生一致的变化。我们得出结论,在基础体内条件下,脂肪酸氧化的抑制会抑制非脓毒症动物的葡萄糖生成并增加外周葡萄糖处置。这些数据支持非肌肉组织中存在葡萄糖 - 脂肪酸循环,并强调了其在脂肪酸氧化受损情况下对全身葡萄糖稳态的重要性。感染会增加非肌肉组织的葡萄糖摄取,而在很大程度上,脂质氧化的抑制无法进一步增强这种摄取。